Clinical Medications Development for Opiate Addiction: Focus on Nonopioids and Opioid Antagonists for the Amelioration of Opiate Withdrawal Symptoms and Relapse Prevention

This publication has 87 references indexed in Scilit:

• Are detoxification programmes effective?
  The Lancet, 1996
• Myths about the treatment of addiction
  The Lancet, 1996
• The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal Medication Development Issues for Opiate Addiction
  Neuropsychopharmacology, 1995
• A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence
  Alcohol, Clinical and Experimental Research, 1994
• Clonidine is not a Useful Adjunct to Methadone Gradual Detoxification in Opioid Addiction
  The British Journal of Psychiatry, 1994
• Use of recombinant human α2-adrenoceptors to characterize subtype selectivity of antagonist binding
  European Journal of Pharmacology: Molecular Pharmacology, 1993
• Naltrexone
  Drugs, 1988
• Opiate detoxification with lofexidine
  Drug and Alcohol Dependence, 1981
• RAPID OPIATE DETOXIFICATION WITH CLONIDINE AND NALOXONE
  The Lancet, 1980
• CLINICAL PHARMACOLOGY OF NARCOTIC ANTAGONISTS*
  Annals of the New York Academy of Sciences, 1978